Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “chimeric”

309 pharma patents match "chimeric" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 309
Index total 30,257
Page 6 / 13

Quick answer

This filtered view shows 309 pharmaceutical patents matching "chimeric" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

309 results for “chimeric” · 30,257 patents in full index Clear search

  1. US 11253546

    Bispecific OR-gate chimeric antigen receptor responsive to CD19 and CD20

    The Regents of the University of California · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  2. US 11242377

    Chimeric receptor with ligand binding exodomain and cytokine and T cell signalling endodomains

    AUTOLUS LIMITED · Granted Feb 8, 2022 · Expires Feb 3, 2042

    granted

  3. US 11236161

    Chimeric antigen receptors targeting CD-19

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  4. US 11220535

    Anti-BCMA chimeric antigen receptors

    Cartesian Therapeutics, Inc. · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted

  5. US 11192936

    Factor VIII chimeric proteins and uses thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted

  6. US 11186647

    Chimeric antigen receptors targeting BCMA and methods of use thereof

    LEGEND BIOTECH USA INC. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  7. US 11180553

    Chimeric antigen receptor

    AUTOLUS LIMITED · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted

  8. US 11168316

    Chimeric clotting factors

    BIOVERATIV THERAPEUTICS INC. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted

  9. US 11168125

    Immunoglobulin chimeric monomer-dimer hybrids

    BIOVERATIV THERAPEUTICS INC. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted

  10. US 11160833

    Bispecific OR-gate chimeric antigen receptor responsive to CD19 and CD20

    The Regents of the University of California · Granted Nov 2, 2021 · Expires Oct 28, 2041

    granted

  11. US 11161908

    BAFF-R targeted chimeric antigen receptor-modified t-cells and uses thereof

    The Board of Regents of the University of Texas System · Granted Nov 2, 2021 · Expires Oct 28, 2041

    granted

  12. US 11149073

    ROR1-specific chimeric antigen receptors (CAR) with humanized targeting domains

    Julius-Maximilians-Universitat Wurzburg · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted

  13. US 11124541

    Chimeric melanocortin ligands and methods of use thereof

    Regents of the University of Minnesota · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted

  14. US 11111310

    Chimeric polypeptides and methods of altering the membrane localization of the same

    Cell Design Labs, Inc. · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted

  15. US 11103532

    Chimeric protein

    AUTOLUS LIMITED · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted

  16. US 11091532

    T cell which co-expresses a CD19 chimeric antigen receptor and a CD22 chimeric antigen receptor

    AUTOLUS LIMITED · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted

  17. US 11077178

    Chimeric antigen receptor (CAR) that targets chemokine receptor CCR4 and its use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted

  18. US 11072644

    Inhibitory chimeric antigen receptors

    Allogene Therapeutics, Inc. · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted

  19. US 11066674

    Chimeric antigen receptors targeting b-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  20. US 11059879

    Chimeric antigen receptor molecules and uses thereof

    The Board of Regents of the University of Texas System · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted

  21. US 11058722

    Chimeric antigen receptor comprising a cartilage-oligomeric matrix protein (comp) coiled-coil spacer domain

    AUTOLUS LIMITED · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted

  22. US 11059880

    Redirected cells with MHC chimeric receptors and methods of use in immunotherapy

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted

  23. US 11041023

    Chimeric antigen receptors for phagocytosis

    The Regents of the University of California · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted

  24. US 11034933

    Methods for selectively expanding and enriching cells transduced with chimeric antigen receptors and treating HIV infection

    The Regents of the University of California · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.